Avadel Pharmaceuticals plc (AVDL) Net Income by Year
Avadel Pharmaceuticals plc reported a net loss of $48.8M in fiscal year 2024. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q4 FY2024 through Q3 FY2025, the same line adds up to a $278K net loss. The table below carries 15 fiscal years, from 2010 to 2024, and the quarters Avadel Pharmaceuticals plc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
AVDL Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K | FY1010-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$278K | -$48.8Mn/m | -$160.3Mn/m | -$137.5Mn/m | -$77.3M-1200.3% | $7.0Mn/m | -$33.2Mn/m | -$95.3M-239.6% | $68.3Mn/m | -$41.3M-198.8% | $41.8Mn/m | -$85.5Mn/m | -$42.9Mn/m | -$3.2Mn/m | -$8.8Mn/m | -$9.0M |
TTM is the trailing twelve months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.
AVDL Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Avadel Pharmaceuticals plc financials
Frequently Asked Questions
What was Avadel Pharmaceuticals plc's net income in fiscal year 2024?
Avadel Pharmaceuticals plc reported a net loss of $48.8M in fiscal year 2024.
How fast is Avadel Pharmaceuticals plc's net income growing?
Avadel Pharmaceuticals plc (AVDL) reported a $160.3M net loss in fiscal year 2023 and a $48.8M net loss in fiscal year 2024. A growth rate is not meaningful here, because the earlier figure was zero or negative.
What is Avadel Pharmaceuticals plc's net income over the last twelve months?
Avadel Pharmaceuticals plc (AVDL) reported a $278K net loss over the trailing 12 months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.
How has Avadel Pharmaceuticals plc's net income changed over the years?
Across the 15 fiscal years this page covers, Avadel Pharmaceuticals plc (AVDL) net income went from -$9.0M in fiscal year 2010 to -$48.8M in fiscal year 2024.
What was Avadel Pharmaceuticals plc's net income in the most recent quarter?
Avadel Pharmaceuticals plc (AVDL) reported $20K in net income in Q3 2025. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Avadel Pharmaceuticals plc (AVDL) reported on that line in every period on record.